- Home
- WEST vs UPB Comparison
WEST vs UPB Comparison
Compare WEST & UPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WEST
- UPB
- Stock Information
- Founded
- WEST 2009
- UPB 2021
- Country
- WEST United States
- UPB United States
- Employees
- WEST N/A
- UPB N/A
- Industry
- WEST Beverages (Production/Distribution)
- UPB
- Sector
- WEST Consumer Staples
- UPB
- Exchange
- WEST Nasdaq
- UPB NYSE
- Market Cap
- WEST 640.7M
- UPB 521.3M
- IPO Year
- WEST N/A
- UPB 2024
- Fundamental
- Price
- WEST $6.26
- UPB $11.64
- Analyst Decision
- WEST Strong Buy
- UPB Strong Buy
- Analyst Count
- WEST 5
- UPB 4
- Target Price
- WEST $10.60
- UPB $56.50
- AVG Volume (30 Days)
- WEST 273.1K
- UPB 501.0K
- Earning Date
- WEST 08-07-2025
- UPB 08-14-2025
- Dividend Yield
- WEST N/A
- UPB N/A
- EPS Growth
- WEST N/A
- UPB N/A
- EPS
- WEST N/A
- UPB N/A
- Revenue
- WEST $872,022,000.00
- UPB $2,296,000.00
- Revenue This Year
- WEST $22.72
- UPB N/A
- Revenue Next Year
- WEST $14.75
- UPB N/A
- P/E Ratio
- WEST N/A
- UPB N/A
- Revenue Growth
- WEST 2.38
- UPB N/A
- 52 Week Low
- WEST $5.28
- UPB $5.14
- 52 Week High
- WEST $10.17
- UPB $29.46
- Technical
- Relative Strength Index (RSI)
- WEST 47.75
- UPB N/A
- Support Level
- WEST $5.65
- UPB N/A
- Resistance Level
- WEST $6.54
- UPB N/A
- Average True Range (ATR)
- WEST 0.28
- UPB 0.00
- MACD
- WEST 0.04
- UPB 0.00
- Stochastic Oscillator
- WEST 61.81
- UPB 0.00
About WEST Westrock Coffee Company
Westrock Coffee Co is an integrated coffee, tea, flavors, extracts, and ingredients solutions provider in the U.S, providing coffee sourcing, supply chain management, product development, roasting, packaging, and distribution services to retail, foodservice and restaurant, convenience store and travel center, non-commercial account, CPG, and hospitality industries around the world. The company's segment includes Beverage Solutions and Sustainable Sourcing and Traceability. It generates maximum revenue from the Beverage Solutions segment.
About UPB UPSTREAM BIO INC
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine that is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune-mediated diseases.